Biosante Pharmaceuticals Aktie

Kaufen

Verkaufen

53,50 EUR +1,00 EUR +1,90 %

22.11.24

STU

56,81 USD +1,02 USD +1,83 %

22.11.24

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 1,13 Mrd. EUR

KGV 58,49 Div. Rendite 0,00%

16.10.17	Biosante Pharmaceuticals Buy	Canaccord Adams
31.07.17	Biosante Pharmaceuticals Buy	Canaccord Adams
24.05.16	Biosante Pharmaceuticals Hold	Standpoint Research
13.11.15	Biosante Pharmaceuticals Buy	Standpoint Research
28.09.15	Biosante Pharmaceuticals Buy	ROTH Capital Partners, LLC
05.08.15	Biosante Pharmaceuticals Outperform	Oppenheimer & Co. Inc.
04.08.15	Biosante Pharmaceuticals Neutral	ROTH Capital Partners, LLC
31.07.15	Biosante Pharmaceuticals Outperform	Oppenheimer & Co. Inc.
Werbung
15.07.15	Biosante Pharmaceuticals Neutral	ROTH Capital Partners, LLC
23.06.15	Biosante Pharmaceuticals Outperform	Oppenheimer & Co. Inc.
18.05.15	Biosante Pharmaceuticals Neutral	ROTH Capital Partners, LLC
06.05.15	Biosante Pharmaceuticals Outperform	Oppenheimer & Co. Inc.
10.04.15	Biosante Pharmaceuticals Neutral	ROTH Capital Partners, LLC
26.02.15	Biosante Pharmaceuticals Buy	ROTH Capital Partners, LLC
18.02.15	Biosante Pharmaceuticals Outperform	Oppenheimer & Co. Inc.
20.11.14	Biosante Pharmaceuticals Buy	ROTH Capital Partners, LLC